Search
Descriptor in English: Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Descriptor in Spanish: Combinación Efavirenz, Emtricitabina y Fumarato de Tenofovir Disoproxil
Descriptor in Portuguese: Combinação Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila
Descriptor in French: Association d'éfavirenz, d'emtricitabine et de fumarate de ténofovir disoproxil
Entry term(s): Atripla
Tree number(s): D02.705.429.906.125
D03.383.533.375
D03.383.742.680.245.500.600.125
D03.633.100.759.138.881.125
D26.310.375
Scope note: Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
History Note: 2016 (2007)
See also the descriptors: Antiretroviral Therapy, Highly Active MeSH
DeCS UI: 55901
Descriptor UI: D000068257
Date Established: 2016/01/01
Date of Entry: 2015/07/10
Revision Date: 2019/04/29
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - Preferred
Concept UI M0548057
Scope note Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.
Preferred term Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Atripla - Narrower
Concept UI M0507695
Preferred term Atripla



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey